Fixed-dose combination medications for non-communicable diseases

[1] [Anonymous], 2013, GLOB ACT PLAN PREV C

[2] Medication errors in elderly people: contributing factors and future perspectives [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 67 (06) : 641 - 645

[3] 2013 ESH/ESC Guidelines for themanagement of arterial hypertension The Task Force for the management ofarterial hypertension of the European Society ofHypertension (ESH) and of the European Society of Cardiology (ESC) [J]. JOURNAL OF HYPERTENSION, 2013, 31 (07) : 1281 - 1357

[4] Global Disparities of Hypertension Prevalence and Control A Systematic Analysis of Population-Based Studies From 90 Countries [J]. CIRCULATION, 2016, 134 (06) : 441 - +

[5] Fixed-dose combination antihypertensives and risk of medication errors [J]. HEART, 2019, 105 (03) : 204 - 209

[6] 2016 European Guidelines on cardiovascular disease prevention in clinical practice [J]. EUROPEAN HEART JOURNAL, 2016, 37 (29) : 2315 - +

[7] Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: A population-based retrospective cohort study [J]. PLOS MEDICINE, 2018, 15 (06)

[8] Putting polypills into practice: challenges and lessons learned [J]. LANCET, 2017, 389 (10073) : 1066 - 1074

[9] 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines (vol 71, pg e127, 2018) [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (19) : 2275 - 2279

[10] Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey [J]. LANCET, 2011, 378 (9798) : 1231 - 1243

[1] [Anonymous], 2013, GLOB ACT PLAN PREV C

[2] Medication errors in elderly people: contributing factors and future perspectives [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 67 (06) : 641 - 645

[3] 2013 ESH/ESC Guidelines for themanagement of arterial hypertension The Task Force for the management ofarterial hypertension of the European Society ofHypertension (ESH) and of the European Society of Cardiology (ESC) [J]. JOURNAL OF HYPERTENSION, 2013, 31 (07) : 1281 - 1357

[4] Global Disparities of Hypertension Prevalence and Control A Systematic Analysis of Population-Based Studies From 90 Countries [J]. CIRCULATION, 2016, 134 (06) : 441 - +

[5] Fixed-dose combination antihypertensives and risk of medication errors [J]. HEART, 2019, 105 (03) : 204 - 209

[6] 2016 European Guidelines on cardiovascular disease prevention in clinical practice [J]. EUROPEAN HEART JOURNAL, 2016, 37 (29) : 2315 - +

[7] Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: A population-based retrospective cohort study [J]. PLOS MEDICINE, 2018, 15 (06)

[8] Putting polypills into practice: challenges and lessons learned [J]. LANCET, 2017, 389 (10073) : 1066 - 1074

[9] 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines (vol 71, pg e127, 2018) [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (19) : 2275 - 2279

[10] Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey [J]. LANCET, 2011, 378 (9798) : 1231 - 1243